Abstract:Early hematopoiesis is a continuous process in which hematopoietic stem and progenitor cells (HSPCs) gradually differentiate toward specific lineages. Aging and myeloid malignant transformation are characterized by changes in the composition and regulation of HSPCs. In this study, we used single-cell RNA sequencing (scRNA-seq) to characterize an enriched population of human HSPCs obtained from young and elderly healthy individuals. Based on their transcriptional profile, we identified changes in the proportions of progenitor compartments during aging, and differences in their functionality, as evidenced by gene set enrichment analysis. Trajectory inference revealed that altered gene expression dynamics accompanied cell differentiation, which could explain aging-associated changes in hematopoiesis. Next, we focused on key regulators of transcription by constructing gene regulatory networks (GRNs) and detected regulons that were specifically active in elderly individuals. Using previous findings in healthy cells as a reference, we analyzed scRNA-seq data obtained from patients with myelodysplastic syndrome (MDS) and detected specific alterations of the expression dynamics of genes involved in erythroid differentiation in all patients with MDS such as TRIB2. In addition, the comparison between transcriptional programs and GRNs regulating normal HSPCs and MDS HSPCs allowed identification of regulons that were specifically active in MDS cases such as SMAD1, HOXA6, POU2F2, and RUNX1 suggesting a role of these transcription factors (TFs) in the pathogenesis of the disease. In summary, we demonstrate that the combination of single-cell technologies with computational analysis tools enable the study of a variety of cellular mechanisms involved in complex biological systems such as early hematopoiesis and can be used to dissect perturbed differentiation trajectories associated with perturbations such as aging and malignant transformation. Furthermore, the identification of abnormal regulatory mechanisms associated with myeloid malignancies could be exploited for personalized therapeutic approaches in individual patients.

Haematopoietic ageing through the lens of single-cell technologies

Unveiling Aging Dynamics in the Hematopoietic System Insights from Single-Cell Technologies

Single Cell Transcriptomics to Understand HSC Heterogeneity and Its Evolution upon Aging

Increasing Complexity of Molecular Landscapes in Human Hematopoietic Stem and Progenitor Cells during Development and Aging

Forward single-cell sequencing into clinical application: Understanding of ageing and rejuvenation from clinical observation to single-cell solution

Deciphering the aging process through single‐cell cytometric technologies

Progress in Hematopoietic Stem Cell Ageing Research

Understanding intrinsic hematopoietic stem cell aging

Molecular Markers of Blood Cell Populations Can Help Estimate Aging of the Immune System

Cellular and Molecular Mechanisms Involved in Hematopoietic Stem Cell Aging as a Clinical Prospect

Investigation of human aging at the single-cell level

Single-cell RNA-seq reveals a concomitant delay in differentiation and cell cycle of aged hematopoietic stem cells

Single-cell RNA-seq reveals changes in cell cycle and differentiation programs upon aging of hematopoietic stem cells

A life‐time of hematopoietic cell function: ascent, stability, and decline

Mechanisms and rejuvenation strategies for aged hematopoietic stem cells

Molecular and cellular mechanisms of aging in hematopoietic stem cells and their niches

Aging of the Hematopoietic Stem Cell Niche: New Tools to Answer an Old Question

Aging is associated with functional and molecular changes in distinct hematopoietic stem cell subsets

Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single-cell resolution

Utilizing blood single-cell transcriptomics to integrate intrinsic and systemic immune aging

Molecular hallmarks of heterochronic parabiosis at single-cell resolution